About MRI Interventions (OTCMKTS:MRIC)
MRI Interventions, Inc. (MRI Interventions), formerly SurgiVision, Inc., is a medical device company that develops and commercializes platforms for procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The Company has two product platforms. Its ClearPoint system, which is in commercial use in the United States, is used to perform minimally invasive surgical procedures in the brain. Its ClearTrace system, which is still in development, will be used to perform minimally invasive surgical procedures in the heart. Both systems utilize intra-procedural magnetic resonance imaging to guide the procedures. Both systems are designed to work in a hospital's existing MRI suite. Its ClearPoint system is designed to allow minimally invasive procedures in the brain to be performed in a hospital's existing MRI suite. MRI Interventions's ClearTrace system is designed to deliver therapies to treat certain cardiac diseases.
Industry, Sector and Symbol
Industry Medical Appliances & Equipment
Trailing P/E Ratio-1.74657534246575
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
MRI Interventions (OTCMKTS:MRIC) Frequently Asked Questions
What is MRI Interventions' stock symbol?
MRI Interventions trades on the OTCMKTS under the ticker symbol "MRIC."
How were MRI Interventions' earnings last quarter?
MRI Interventions Inc (OTCMKTS:MRIC) announced its quarterly earnings results on Monday, November, 6th. The company reported ($0.14) earnings per share for the quarter. View MRI Interventions' Earnings History.
Who are some of MRI Interventions' key competitors?
Some companies that are related to MRI Interventions include Xenon Pharmaceuticals (XENE), OptiBiotix Health (OPTI), TRACON Pharmaceuticals (TCON), Reshape Lifesciences (RSLS), Ocera Therapeutics (OCRX), Electromed (ELMD), Vernalis (VER), Avacta Group (AVCT), Concordia International (CXR), Immutep (IMMP), ANGLE (AGL), Cleveland BioLabs (CBLI), Celsion (CLSN), Egalet (EGLT), Microbot Medical (MBOT), Evoke Pharma (EVOK), OvaScience (OVAS) and Futura Medical (FUM).
Who are MRI Interventions' key executives?
MRI Interventions' management team includes the folowing people:
- Kimble L. Jenkins, Chairman of the Board (Age 55)
- Joseph Michael Burnett, President, Chief Executive Officer, Director (Age 34)
- Harold A. Hurwitz, Chief Financial Officer, Secretary (Age 65)
- Peter G. Piferi, Chief Operating Officer (Age 57)
- Wendelin C. Maners, Vice President - Sales and Marketing (Age 54)
- R. John Fletcher, Director (Age 71)
- Pascal E.R. Girin, Independent Director (Age 57)
- Timothy T. Richards, Independent Director (Age 59)
- Maria Degois Sainz, Independent Director (Age 51)
- John N. Spencer Jr., CPA, Independent Director (Age 76)
How do I buy MRI Interventions stock?
Shares of MRI Interventions can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is MRI Interventions' stock price today?
One share of MRI Interventions stock can currently be purchased for approximately $2.55.
How big of a company is MRI Interventions?
MRI Interventions has a market capitalization of $26.21 million.
How can I contact MRI Interventions?
MRI Interventions' mailing address is 5 Musick, IRVINE, CA 92618-1638, United States. The company can be reached via phone at +1-949-9006833.
MarketBeat Community Rating for MRI Interventions (MRIC)MarketBeat's community ratings are surveys of what our community members think about MRI Interventions and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
MRI Interventions (OTCMKTS:MRIC) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
MRI Interventions (OTCMKTS:MRIC) Earnings History and Estimates Chart
MRI Interventions (OTCMKTS MRIC) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|4/27/2017||Q1 2017||($0.46)||$2.01 million||View||N/A|
|2/28/2017||Q4 2016||($0.02)||($0.47)||$1.64 million||View||Listen|
|3/5/2015||Q414||($0.03)||($0.03)||$1.11 million||$0.96 million||View||N/A|
|11/13/2014||Q3 2014||($0.03)||($0.06)||$0.63 million||View||N/A|
|8/7/2014||Q2 2014||($0.04)||($0.03)||$1.19 million||View||N/A|
MRI Interventions (OTCMKTS:MRIC) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for MRI Interventions (OTCMKTS:MRIC)
No dividend announcements for this company have been tracked by MarketBeat.com
MRI Interventions (OTCMKTS MRIC) Insider Trading and Institutional Ownership History
MRI Interventions (OTCMKTS MRIC) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|9/12/2014||John N Spencer Jr||Director||Buy||16,000||$1.18||$18,880.00|| |
|8/13/2014||John N Spencer Jr||Director||Buy||3,500||$1.00||$3,500.00|| |
|6/13/2014||Andrew K Rooke||Director||Buy||30,000||$0.73||$21,900.00|| |
|6/10/2014||Andrew K Rooke||Director||Buy||50,000||$0.78||$39,000.00|| |
|8/19/2013||Michael Pietrangelo||Director||Buy||100,000||$1.27||$127,000.00|| |
|6/11/2013||Michael Pietrangelo||Director||Buy||41,855||$1.10||$46,040.50|| |
|5/13/2013||John N Spencer Jr||Director||Buy||1,500||$1.32||$1,980.00|| |
|3/22/2013||Bruce C Conway||Director||Buy||2,500||$1.48||$3,700.00|| |
|3/20/2013||Bruce C Conway||Director||Buy||2,500||$1.50||$3,750.00|| |
|3/14/2013||Bruce C Conway||Director||Buy||32,665||$1.50||$48,997.50|| |
|3/13/2013||Bruce C Conway||Director||Buy||2,000||$1.50||$3,000.00|| |
|3/11/2013||Bruce C Conway||Director||Buy||28,550||$1.54||$43,967.00|| |
|9/14/2012||Bruce C Conway||Director||Buy||4,000||$2.19||$8,760.00|| |
|9/13/2012||Bruce C Conway||Director||Buy||18,750||$2.05||$38,437.50|| |
|9/11/2012||Bruce C Conway||Director||Buy||22,500||$2.14||$48,150.00|| |
|9/6/2012||Bruce C Conway||Director||Buy||4,600||$2.23||$10,258.00|| |
|8/27/2012||Bruce C Conway||Director||Buy||20,900||$2.39||$49,951.00|| |
|8/24/2012||Bruce C Conway||Director||Buy||14,500||$2.43||$35,235.00|| |
|8/21/2012||Bruce C Conway||Director||Buy||8,000||$2.38||$19,040.00|| |
|8/15/2012||Bruce C Conway||Director||Buy||31,950||$2.47||$78,916.50|| |
MRI Interventions (OTCMKTS MRIC) News Headlines
MRI Interventions (OTCMKTS:MRIC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
MRI Interventions (OTCMKTS MRIC) Stock Chart for Sunday, January, 21, 2018